VUKOTIC, Ranka
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.022
AS - Asia 2.187
EU - Europa 1.736
SA - Sud America 270
Continente sconosciuto - Info sul continente non disponibili 72
AF - Africa 69
OC - Oceania 5
Totale 9.361
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.884
SG - Singapore 658
CN - Cina 466
PL - Polonia 324
HK - Hong Kong 309
GB - Regno Unito 306
VN - Vietnam 285
IT - Italia 269
SE - Svezia 195
BR - Brasile 189
FI - Finlandia 175
BD - Bangladesh 154
DE - Germania 104
RU - Federazione Russa 102
CA - Canada 70
KR - Corea 64
IN - India 48
BG - Bulgaria 39
UA - Ucraina 35
ES - Italia 31
FR - Francia 31
TR - Turchia 30
JP - Giappone 29
AR - Argentina 26
ID - Indonesia 26
NL - Olanda 25
ZA - Sudafrica 24
AE - Emirati Arabi Uniti 21
MX - Messico 19
IQ - Iraq 18
CZ - Repubblica Ceca 15
CO - Colombia 14
AT - Austria 13
CR - Costa Rica 13
VE - Venezuela 12
LT - Lituania 11
MA - Marocco 10
RO - Romania 10
CL - Cile 9
PH - Filippine 9
PK - Pakistan 9
EG - Egitto 8
MY - Malesia 8
DZ - Algeria 7
ET - Etiopia 7
IE - Irlanda 7
PE - Perù 7
DO - Repubblica Dominicana 6
IL - Israele 6
SA - Arabia Saudita 6
AL - Albania 5
AU - Australia 5
BE - Belgio 5
CH - Svizzera 5
GR - Grecia 5
GT - Guatemala 5
NI - Nicaragua 5
PR - Porto Rico 5
PY - Paraguay 5
TN - Tunisia 5
UZ - Uzbekistan 5
EE - Estonia 4
JM - Giamaica 4
JO - Giordania 4
NP - Nepal 4
QA - Qatar 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EC - Ecuador 3
GE - Georgia 3
KH - Cambogia 3
KZ - Kazakistan 3
RS - Serbia 3
TH - Thailandia 3
UY - Uruguay 3
BO - Bolivia 2
GH - Ghana 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
MT - Malta 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AW - Aruba 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CD - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GD - Grenada 1
HT - Haiti 1
Totale 9.279
Salva come PNG Salva come JPEG
Città #
Ashburn 627
Santa Clara 563
Singapore 440
Warsaw 319
Fairfield 313
Hong Kong 305
Chandler 303
San Jose 220
Council Bluffs 169
Helsinki 168
Houston 162
Nyköping 157
Woodbridge 124
Wilmington 113
Cambridge 108
Los Angeles 107
Beijing 105
Southend 104
London 101
Seattle 100
Chicago 98
Ho Chi Minh City 89
New York 89
Hanoi 74
The Dalles 56
San Diego 55
Seoul 55
Hefei 51
Ann Arbor 49
Boardman 47
Moscow 46
Salt Lake City 45
Dearborn 44
Princeton 41
Sofia 38
Orem 36
Buffalo 33
Jacksonville 33
Milan 31
Shanghai 31
Modena 30
Oakland 30
Dallas 29
São Paulo 26
Tokyo 25
Da Nang 20
Frankfurt am Main 20
Jakarta 20
Palma 18
Jersey City 17
Haiphong 16
Redwood City 16
North Bergen 15
Brooklyn 14
Tampa 14
Toronto 14
Izmir 13
Vancouver 13
Washington 13
Brno 12
Denver 12
Phoenix 12
Bologna 11
Elk Grove Village 11
Johannesburg 11
Wuhan 11
Baghdad 10
Belo Horizonte 10
Bremen 10
Columbus 10
Guangzhou 10
Montreal 10
Nanjing 10
Reading 10
Redondo Beach 10
Rome 10
Saint Augustine 10
San José 10
Sterling 10
Berlin 9
Charlotte 9
Chennai 9
Falls Church 9
Grafing 9
Kilburn 9
Miami 9
Newark 9
San Francisco 9
Augusta 8
Cairo 8
Chiswick 8
Eugene 8
Istanbul 8
Miano 8
New Delhi 8
Stanford 8
Vienna 8
Addis Ababa 7
Amsterdam 7
Groningen 7
Totale 6.396
Salva come PNG Salva come JPEG
Nome #
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 646
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 482
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 420
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C 390
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 357
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 340
Reproductive status is associated with the severity of fibrosis in women with hepatitis C. 317
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: A case-control study 309
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing 277
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 242
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C 228
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 226
Clinical and serological profile of primary biliary cirrhosis in men 226
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 225
Familial intrahepatic cholestasis: New and wide perspectives 220
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 217
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 213
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 197
Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods 195
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 191
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B 190
De novo autoimmune hepatitis in liver transplant: State-of-the-art review 189
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 188
Hepatitis C Virus Core Antigen (HCVAg): An affordable assay to monitor the efficacy of treatment in DAAs era 188
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 173
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 173
Bone marrow derived stem cells for the treatment of end-stage liver disease 172
Hepatitis B virus and immune response 160
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 160
Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group 159
Insights into cancer severity from biomolecular interaction mechanisms 157
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 154
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 150
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study 150
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study 146
Impact of psychosocial status on liver transplant process 141
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 140
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 138
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir? 135
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 130
Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy options 126
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma 124
Totale 9.361
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.726
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022598 0 0 0 40 16 51 23 87 83 77 123 98
2022/2023746 108 105 69 78 74 114 11 67 81 4 21 14
2023/2024455 21 25 27 70 102 21 43 47 5 6 21 67
2024/20251.530 47 12 4 121 353 241 67 121 171 102 118 173
2025/20263.704 188 63 165 322 535 547 406 191 389 376 319 203
2026/2027990 160 230 240 360 0 0 0 0 0 0 0 0
Totale 9.361